Victrex (LON:VCT – Get Free Report) had its price objective reduced by Berenberg Bank from GBX 990 ($13.29) to GBX 880 ($11.81) in a research report issued to clients and investors on Thursday, MarketBeat reports. The brokerage presently has a “hold” rating on the stock. Berenberg Bank’s target price points to a potential upside of 25.89% from the stock’s previous close.
VCT has been the subject of a number of other research reports. JPMorgan Chase & Co. lowered their price target on Victrex from GBX 940 ($12.62) to GBX 818 ($10.98) and set a “neutral” rating for the company in a report on Wednesday, July 9th. Deutsche Bank Aktiengesellschaft lowered Victrex to a “hold” rating and lowered their price target for the company from GBX 990 ($13.29) to GBX 850 ($11.41) in a report on Tuesday, July 8th. Finally, Citigroup lowered their price target on Victrex from GBX 870 ($11.68) to GBX 740 ($9.93) and set a “neutral” rating for the company in a report on Friday.
Read Our Latest Stock Analysis on Victrex
Victrex Stock Up 0.1%
Victrex (LON:VCT – Get Free Report) last announced its earnings results on Monday, May 12th. The company reported GBX 22.60 ($0.30) earnings per share (EPS) for the quarter. Victrex had a return on equity of 6.67% and a net margin of 10.81%. On average, equities analysts predict that Victrex will post 73.1078905 EPS for the current year.
Insiders Place Their Bets
In related news, insider Dame Vivienne Cox bought 2,747 shares of the stock in a transaction on Tuesday, July 8th. The stock was bought at an average price of GBX 721 ($9.68) per share, for a total transaction of £19,805.87 ($26,585.06). Also, insider David Thomas bought 1,158 shares of the stock in a transaction on Tuesday, May 13th. The shares were bought at an average price of GBX 846 ($11.36) per share, with a total value of £9,796.68 ($13,149.91). 1.64% of the stock is owned by corporate insiders.
Victrex Company Profile
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.
Featured Articles
- Five stocks we like better than Victrex
- What is a support level?
- Why Pure Storage Is a Core Investment for the AI Era
- Stock Average Calculator
- 2025: A Pivotal Year for Smart Glasses As Meta Invests in Ray-Ban
- 3 Defense Stocks Set to Benefit From Increased Military Spending
- Unity’s New Ad Solutions Drive Stock to 52-Week High
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.